EP1572987A4 - Neuartige nukleinsäure und polypeptide - Google Patents

Neuartige nukleinsäure und polypeptide

Info

Publication number
EP1572987A4
EP1572987A4 EP01907128A EP01907128A EP1572987A4 EP 1572987 A4 EP1572987 A4 EP 1572987A4 EP 01907128 A EP01907128 A EP 01907128A EP 01907128 A EP01907128 A EP 01907128A EP 1572987 A4 EP1572987 A4 EP 1572987A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
novel nucleic
novel
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01907128A
Other languages
English (en)
French (fr)
Other versions
EP1572987A2 (de
Inventor
Y Tom Tang
Chenghua Liu
Radoje T Drmanac
Vinod Asundi
Ping Zhou
Chongjun Xu
Yicheng Cao
Yunquing Ma
Qing A Zhao
Dunrui Wang
Jian-Rui Wang
Jie Zhang
Feiyan Ren
Rui-Hong Chen
Zhi Wei Wang
Aidong J Xue
Yonghong Yang
Tom Wejhrman
Ryle Goodrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/728,422 external-priority patent/US20020128187A1/en
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1572987A2 publication Critical patent/EP1572987A2/de
Publication of EP1572987A4 publication Critical patent/EP1572987A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP01907128A 2000-02-03 2001-02-05 Neuartige nukleinsäure und polypeptide Withdrawn EP1572987A4 (de)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US728422 1991-07-11
US49691400A 2000-02-03 2000-02-03
US496914 2000-02-03
US56087500A 2000-04-27 2000-04-27
US560875 2000-04-27
US59807500A 2000-06-20 2000-06-20
US598075 2000-06-20
US62032500A 2000-07-19 2000-07-19
US620325 2000-07-19
US65493600A 2000-09-01 2000-09-01
US654936 2000-09-01
US66356100A 2000-09-15 2000-09-15
US663561 2000-09-15
US69332500A 2000-10-20 2000-10-20
US693325 2000-10-20
US09/728,422 US20020128187A1 (en) 2000-02-03 2000-11-30 Novel nucleic acids and polypeptides
PCT/US2001/004098 WO2001057190A2 (en) 2000-02-03 2001-02-05 Novel nucleic acids and polypeptides

Publications (2)

Publication Number Publication Date
EP1572987A2 EP1572987A2 (de) 2005-09-14
EP1572987A4 true EP1572987A4 (de) 2005-11-30

Family

ID=27575454

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01907128A Withdrawn EP1572987A4 (de) 2000-02-03 2001-02-05 Neuartige nukleinsäure und polypeptide

Country Status (4)

Country Link
EP (1) EP1572987A4 (de)
AU (1) AU2001234944A1 (de)
CA (1) CA2399776A1 (de)
WO (1) WO2001057190A2 (de)

Families Citing this family (168)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7057017B2 (en) 1997-04-16 2006-06-06 Millennium Pharmaceuticals, Inc. Human dickkopf-related protein and nucleic acid molecules and uses therefor
US20030068623A1 (en) 1997-06-16 2003-04-10 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7446181B2 (en) 1998-01-15 2008-11-04 Millennium Pharmaceuticals, Inc. Antibodies that bind human Dickkopf-1 proteins
EP1086223B1 (de) 1998-06-01 2009-07-29 Agensys, Inc. Serpentintransmembranantigene exprimiert in menschlichem krebs und deren verwendungen
US20030149531A1 (en) 2000-12-06 2003-08-07 Hubert Rene S. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US6833438B1 (en) 1999-06-01 2004-12-21 Agensys, Inc. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US7264801B2 (en) 1998-08-11 2007-09-04 Genentech, Inc. EG-VEGF nucleic acids and polypeptides and method of use
US20020172678A1 (en) 2000-06-23 2002-11-21 Napoleone Ferrara EG-VEGF nucleic acids and polypeptides and methods of use
US20030003507A1 (en) 1999-06-02 2003-01-02 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US6344541B1 (en) 1998-09-25 2002-02-05 Amgen Inc. DKR polypeptides
JP2002534112A (ja) 1999-01-15 2002-10-15 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド 骨髄特異的タンパク質
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
JP2004522402A (ja) * 1999-06-02 2004-07-29 ジェネンテック・インコーポレーテッド 同一のものをコードする分泌及び膜貫通ポリペプチドと核酸
US20030204052A1 (en) * 2000-10-04 2003-10-30 Herrmann John L. Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
AU776341B2 (en) * 1999-08-19 2004-09-02 Kurokawa, Kiyoshi Meg-1 protein
US7790861B2 (en) * 1999-09-24 2010-09-07 Philadelphia Health And Education Corporation Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
US20020042062A1 (en) 1999-09-24 2002-04-11 Mark Stearns Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
CA2389724A1 (en) * 1999-11-12 2001-05-17 Human Genome Sciences, Inc. 28 human secreted proteins
CA2395416A1 (en) 1999-12-23 2001-06-28 Millennium Pharmaceuticals, Inc. P2y12 receptor
WO2001059079A1 (en) 2000-02-11 2001-08-16 Glycozym Aps UDP-GALACTOSE: β-D-GALACTOSE-R 4-α-D-GALACTOSYLTRANSFERASE, α4GAL-T1
JP4342069B2 (ja) * 2000-02-14 2009-10-14 生化学工業株式会社 α１，４−ガラクトース転移酵素およびそれをコードするＤＮＡ
AU6802801A (en) * 2000-03-01 2001-09-24 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1698697A3 (de) * 2000-03-24 2006-09-13 Takeda Pharmaceutical Company Limited SSD-enthaldentes Protein, Verfahren zu deren Herstellung und Verwendung
US20020065223A1 (en) * 2000-06-16 2002-05-30 Glucksmann Maria Alexandra 33358, a novel human ankyrin family member and uses thereof
CA2405104A1 (en) * 2000-04-05 2001-10-18 Kirin Beer Kabushiki Kaisha Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
AU2001268967A1 (en) * 2000-04-18 2001-10-30 Bayer Aktiengesellschaft Regulation of human epithin-like serine protease
AU2001257407A1 (en) * 2000-04-26 2001-11-07 Millennium Pharmaceuticals, Inc. 21657, a human short-chain dehydrogenase and uses thereof
US20030092035A1 (en) 2000-05-04 2003-05-15 Anderson David J. Pain signaling molecules
US7510845B2 (en) 2000-05-04 2009-03-31 California Institute Of Technology Assay employing G protein-coupled receptor expressed in dorsal root ganglia
US7117033B2 (en) 2000-05-08 2006-10-03 Brainsgate, Ltd. Stimulation for acute conditions
WO2001085935A2 (en) * 2000-05-09 2001-11-15 Bayer Aktiengesellschaft Endothelial differentiation gene 6-like g protein coupled receptor
WO2001092494A2 (en) * 2000-05-26 2001-12-06 Millennium Pharmaceuticals, Inc. 50250, a human lipase and uses thereof
AU2001272974A1 (en) * 2000-06-21 2002-01-02 Incyte Genomics, Inc. Human receptors
AU7018801A (en) * 2000-06-26 2002-01-08 Millennium Pharm Inc 46619, a novel human beta-ketoacyl synthase and uses thereof
WO2002002599A2 (en) * 2000-06-30 2002-01-10 Ingenium Pharmaceuticals Ag HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR17, AND USES THEROF
WO2002006312A2 (en) * 2000-07-13 2002-01-24 Novartis Ag Disease-associated gene
AU2001278488A1 (en) * 2000-07-25 2002-02-05 Bayer Aktiengesellschaft Regulation of human matriptase-like serine protease
EP1315431A1 (de) * 2000-08-02 2003-06-04 Millennium Pharmaceuticals, Inc. Ein mitglied der familie der menschlichen gtp-freisetzenden faktoren (15368) und dessen verwendung
JP2004527210A (ja) 2000-08-02 2004-09-09 ザ ジョンズ ホプキンス ユニバーシティー 内皮細胞発現パターンの評価法
US20040053262A1 (en) * 2000-08-04 2004-03-18 Xin Lu Supressor gene
AU2001295454A1 (en) * 2000-08-14 2002-02-25 Bayer Aktiengesellschaft Regulation of human p2y1-like g protein-coupled receptor
EP1688496A3 (de) * 2000-08-14 2006-08-16 Actimis Pharmaceuticals, Inc., Regulierung des menschlichen P2Y1-ähnlichen G-Protein gekoppelten Rezeptors
AU2001284902A1 (en) * 2000-08-15 2002-02-25 Zymogenetics Inc. Human adenosine deaminase
US6706513B2 (en) 2000-08-21 2004-03-16 Bristol-Myers Squibb Company Adenosine deaminase homolog
US20030224396A1 (en) * 2000-08-30 2003-12-04 Yonghong Xiao Regulation of human aminotransferase-like enzyme
US20030166300A1 (en) * 2000-08-30 2003-09-04 Tang Y. Tom Growth-related inflammatory and immune response protein
US20040072185A1 (en) * 2000-09-15 2004-04-15 Patrizia Paterlini-Brechot Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses
US7754435B2 (en) * 2000-09-21 2010-07-13 Philadelphia Health And Education Corporation Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
AU2002220613A1 (en) * 2000-10-11 2002-04-22 Bayer Aktiengesellschaft Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase
AU2001297794A1 (en) 2000-10-19 2002-12-03 Millenium Pharmaceuticals, Inc. Methods and compositions of human proteins and uses thereof.
JP2004532609A (ja) 2000-11-03 2004-10-28 ザ リージェント オブ ザ ユニバーシティ オブ カリフォルニア プロキネチシンポリペプチド、関連組成物および方法
EP1364012A2 (de) * 2000-11-08 2003-11-26 Millennium Pharmaceuticals, Inc. 38650, 28472, 5495, 65507, 81588 and 14354 verfarhren zur herstellung und verwendung davon
WO2002038743A2 (en) * 2000-11-09 2002-05-16 Glaxo Group Limited Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp
IL155800A0 (en) * 2000-11-09 2003-12-23 Univ Virginia Nucleic acid sequences encoding human testis specific kinases
US7312086B2 (en) 2000-12-07 2007-12-25 Bristol-Myers Squibb Company Methods of diagnosing colon adenocarcinoma using the human g-protein coupled receptor hgprbmy23
EP1387888A2 (de) * 2000-12-21 2004-02-11 Incyte Genomics, Inc. Proteine die mit nukleinsäuren assoziiert sind
US7892730B2 (en) * 2000-12-22 2011-02-22 Sagres Discovery, Inc. Compositions and methods for cancer
US20030148920A1 (en) * 2000-12-27 2003-08-07 Steven Rosen Sulfatases and methods of use thereof
WO2002053719A2 (en) * 2001-01-04 2002-07-11 Incyte Genomics, Inc. Cytoskeleton-associated proteins
US20040126759A1 (en) * 2001-01-05 2004-07-01 Baughn Mariah R. Molecules for disease detection and treatment
US6319679B1 (en) * 2001-01-26 2001-11-20 Board Of Regents, The University Of Texas System PAS kinase
US20020115136A1 (en) * 2001-02-07 2002-08-22 Gennady Merkulov Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002064777A2 (de) * 2001-02-14 2002-08-22 Axaron Bioscience Ag Protein 7b6 und 11b4 und zugrundeliegende dna-sequenzen
AU2002258520A1 (en) * 2001-03-16 2002-10-03 Incyte Genomics, Inc. Nucleic acid-associated proteins
US20030044813A1 (en) * 2001-03-30 2003-03-06 Old Lloyd J. Cancer-testis antigens
US20020146795A1 (en) * 2001-04-02 2002-10-10 Shiaoping Zhu Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
US7927597B2 (en) * 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
WO2002083921A2 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
US6962811B2 (en) 2001-05-09 2005-11-08 Millennium Pharmaceuticals, Inc. 14715, a human fringe family member nucleic acids and uses therefor
DE60237518D1 (de) 2001-05-29 2010-10-14 Human Cell Systems Inc Testikulärer carnitintransporter und sein gen
DE60237917D1 (de) 2001-06-05 2010-11-18 Exelixis Inc Gfats als modifikatoren des p53-wegs und verwendungsverfahren
PT2000545E (pt) * 2001-06-20 2011-12-21 Genentech Inc Composições e métodos para o diagnóstico e tratamento do tumor pulmonar
AU2002319261A1 (en) * 2001-06-25 2003-01-08 Bayer Aktiengesellschaft Regulation of human serine/threonine protein kinase nek3
US7494646B2 (en) 2001-09-06 2009-02-24 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
EP2287186B1 (de) 2001-09-06 2014-12-31 Agensys, Inc. Nucleinsäure und entsprechendes Protein, STEAP-1, bei der Behandlung und zum Nachweis von Krebs
WO2003029828A2 (de) * 2001-09-24 2003-04-10 Grünenthal GmbH Screeningverfahren für verschiedene indikationen mit bnpi und/oder dnpi
US7265214B2 (en) 2001-10-19 2007-09-04 Rigel Pharmaceuticals, Inc. Germinal center kinase proteins, compositions and methods of use
WO2003038040A2 (en) * 2001-10-29 2003-05-08 Millennium Pharmaceuticals, Inc. 32235, a human aminotransferase family member and uses therefor
EP1440169A4 (de) * 2001-10-31 2005-09-21 Millennium Pharm Inc Verfahren und zusammensetzungen zur behandlung und diagnose von schmerzspezifischen störungen unter verwendung von 57749
EP1439864A4 (de) 2001-10-31 2004-12-22 Millennium Pharm Inc Verfahren zur behandlung und diagnose tumorigener und angiogener störungen unter verwendung von 32616
EP1310552B1 (de) 2001-11-09 2007-06-13 Proteologics, Inc. Posh Nukleinsäure, Polypeptide und darauf bezogene Verfahren
AU2002360460A1 (en) * 2001-12-03 2003-06-17 Nuvelo, Inc. Methods and materials relating to novel polypeptides and polynucleotides
DE60217711T2 (de) * 2001-12-04 2007-11-15 Develogen Aktiengesellschaft Ptp10d nukleinsäuren und peptide in der regulation von energie-homeostase
WO2003054153A2 (en) * 2001-12-12 2003-07-03 University Of Cincinnati Apyrase polypeptides and nucleic acids encoding same
US7858297B2 (en) 2001-12-18 2010-12-28 Centre National De La Recherche Scientifique Cnrs Chemokine-binding protein and methods of use
CA2471777A1 (en) * 2001-12-18 2003-06-26 Endocube Sas Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
AU2003244347A1 (en) * 2002-02-04 2003-09-02 Takeda Chemical Industries, Ltd. Angiogenesis inhibitors
GB0205112D0 (en) * 2002-03-05 2002-04-17 Pantherix Ltd Enzyme
JP4176022B2 (ja) 2002-03-11 2008-11-05 独立行政法人科学技術振興機構 実用的キラルジルコニウム触媒
DE10212397A1 (de) * 2002-03-20 2003-10-16 Universitaetsklinikum Freiburg Repressor der Skelettmuskeldifferenzierung, dafür kodierende Nucleinsäure und dessen Verwendung in Diagnostik und Therapie
WO2003086462A1 (fr) * 2002-03-29 2003-10-23 Celestar Lexico-Sciences,Inc. Inhibiteurs de phosphorylation c-jun
WO2003082342A1 (en) * 2002-04-01 2003-10-09 National Institute Of Advanced Industrial Science And Technology Application of kiaa0172 gene to treatment and diagnosis of diseases and drug discovery
WO2003091447A2 (en) 2002-04-26 2003-11-06 California Institute Of Technology D1-1 nucleic acids, polypeptides and related methods
US7622443B2 (en) 2002-04-26 2009-11-24 California Institute Of Technology Method for inhibiting pro-angiogenic activities of endothelial cells selectively at a site of neoangiogenesis in a mammal by administration of the extracellular domain of D1-1 polypeptides
DE10222845A1 (de) * 2002-05-23 2003-12-04 Dresden Arzneimittel Klonierung, Expression und Charakterisierung der Gesamtsequenz von Phosphodiesterase 8B
EP1572952B1 (de) * 2002-06-28 2010-09-29 Imclone LLC Neue polynukleotid- und polypeptidsequenzen und deren verwendungen
CA2493007A1 (en) * 2002-07-19 2004-01-29 Cellzome Ag Protein complexes of the tip60 transcriptional activator protein
US7135556B2 (en) 2002-07-19 2006-11-14 Schering Corporation NPC1L1 (NPC3) and methods of use thereof
JP2004290170A (ja) * 2002-08-02 2004-10-21 Takeda Chem Ind Ltd 疾患関連遺伝子の用途
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
US7056685B1 (en) 2002-11-05 2006-06-06 Amgen Inc. Receptor ligands and methods of modulating receptors
US7561919B2 (en) 2002-11-14 2009-07-14 Brainsgate Ltd. SPG stimulation via the greater palatine canal
WO2004046342A2 (en) * 2002-11-20 2004-06-03 Biogen Idec Inc. Novel gene targets and ligands that bind thereto for treatment and diagnosis of carcinomas
AU2003300680A1 (en) * 2002-12-10 2004-07-09 Centre National De La Recherche Scientifique Cnrs Thap proteins as nuclear receptors for chemokines and roles in transcriptional regulation, cell proliferation and cell differentiation
JP4140951B2 (ja) * 2002-12-18 2008-08-27 独立行政法人科学技術振興機構 転写制御因子ｚｈｘ３
EP2141235B1 (de) 2002-12-29 2014-06-11 Toudai Tlo, Ltd. Adiponektin-Rezeptor und dafür kodierendes Gen
JP2006518997A (ja) * 2003-01-21 2006-08-24 ブリストル−マイヤーズ　スクイブ　カンパニー 新規アシルコエンザイムａ：モノアシルグリセロールアシルトランスフェラーゼ−３（ｍｇａｔ３）をコードするポリヌクレオチドおよびその用途
US7858346B2 (en) 2003-02-03 2010-12-28 Japan Science Technology Agency Regeneration and neogenesis of retinal visual cell-expressing Otx2 protein
US7749695B2 (en) * 2003-03-03 2010-07-06 Alexander Abbas PRO polypeptides for diagnosis of systemic lupus erythematosis
WO2004098515A2 (en) * 2003-04-30 2004-11-18 Agensys, Inc. Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer
WO2004104218A1 (en) * 2003-05-23 2004-12-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with x-prolyl aminopeptidase (aminopeptidase p) 1 (xpnpep1)
WO2005023855A2 (en) * 2003-09-10 2005-03-17 Friedrich-Alexander-Uni- Versitatet Erlangen- Nuernberg K203 gene and protein
US7534562B2 (en) * 2003-09-30 2009-05-19 Daiichi Pharmaceutical Co., Ltd. Tetrahydrofolate synthetase gene
WO2005059504A2 (en) * 2003-12-12 2005-06-30 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled receptor gpr34 (gpr34)
JP4590417B2 (ja) 2004-01-16 2010-12-01 メルク・シャープ・エンド・ドーム・コーポレイション Ｎｐｃ１ｌ１（ｎｐｃ３）およびこのリガンドの同定方法
EP1723227A4 (de) * 2004-02-10 2007-09-19 Dartmouth College Nicotinamidribosid-kinase-zusammensetzungen und verfahren zu deren verwendung
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
US8055347B2 (en) 2005-08-19 2011-11-08 Brainsgate Ltd. Stimulation for treating brain events and other conditions
WO2005089505A2 (en) 2004-03-19 2005-09-29 Yale University Detection, isolation and uses of renalase (monoamine oxidase c)
AU2005229434B2 (en) * 2004-03-30 2010-09-30 Nsgene A/S Therapeutic use of a growth factor, NsG33
US20050222040A1 (en) * 2004-04-05 2005-10-06 Blm Group, Inc. Vertebrate peptide modulators of lipid metabolism
AU2004319915B9 (en) 2004-04-22 2011-12-22 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
WO2006015373A2 (en) 2004-08-04 2006-02-09 Amgen Inc Antibodies to dkk-1
WO2006069592A2 (en) * 2004-12-31 2006-07-06 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg Method for diagnosing an/or predicting preeclampsia and/or related disorders
FI20050011L (fi) * 2005-01-05 2006-07-06 Jurilab Ltd Oy Menetelmä ja testipakkaus tyypin 2 diabetes mellituksen riskin havaitsemiseksi
WO2006074914A2 (en) * 2005-01-13 2006-07-20 Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research Human rna helicase and therapeutic uses thereof
US7521195B1 (en) 2005-07-21 2009-04-21 Celera Corporation Lung disease targets and uses thereof
AU2006315299A1 (en) 2005-11-21 2007-05-24 Yale University Methods of regulating renalase (Monoamine Oxidase C)
US9206242B2 (en) * 2005-11-22 2015-12-08 National University Corporation Nagoya University Application of actin-binding protein to disease associated with cell motility
US7910698B2 (en) 2006-02-24 2011-03-22 Schering Corporation NPC1L1 orthologues
BRPI0717638A2 (pt) 2006-10-27 2013-11-12 Genentech Inc Anticorpors e imunoconjugados e usos para os mesmos
US7960345B2 (en) * 2007-05-02 2011-06-14 Snu R&Db Foundation Angiogenesis inhibitor comprising meteorin as an active ingredient
EP2173379B2 (de) 2007-07-02 2023-07-05 Oncomed Pharmaceuticals, Inc. Zusammensetzungen und verfahren zur behandlung und diagnose von krebs
EP2170374A2 (de) * 2007-07-03 2010-04-07 Andreas Reichert Verfahren zur behandlung von erkrankungen im zusammenhang mit mitochondriendysfunktion
EP2178551A4 (de) * 2007-07-24 2010-07-21 Sanare Invest As Neuartige polypeptide mit antitumorwirkung
EP2227487A1 (de) 2007-12-28 2010-09-15 Novo Nordisk A/S Ddr1-vermittelte zellreinigung endokriner pankreaszellen durch deren vorläufer
DK2195013T3 (da) 2008-07-24 2012-02-06 Nsgene As Terapeutisk anvendelse af en vækstfaktor, METRNL
AU2010226726B8 (en) 2009-03-16 2014-08-14 Pangu Biopharma Limited Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
AR075989A1 (es) 2009-04-10 2011-05-11 Lilly Co Eli Anticuerpo dkk -1 (dickkopf-1) humano disenado por ingenieria
US8815779B2 (en) 2009-09-16 2014-08-26 SwitchGear Genomics, Inc. Transcription biomarkers of biological responses and methods
PH12012500982A1 (en) 2009-11-30 2019-07-10 Genentech Inc Antibodies for treating and diagnosing tumors expressing slc34a2 (tat211=seqid2)
US9127268B2 (en) 2009-12-11 2015-09-08 Atyr Pharma, Inc. Aminoacyl tRNA synthetases for modulating inflammation
CN103096909A (zh) 2010-05-04 2013-05-08 Atyr医药公司 与谷氨酰-脯氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
KR20130102534A (ko) 2010-07-12 2013-09-17 에이티와이알 파마, 인코포레이티드 히스티딜­trna 합성효소의 단백질 단편에 관련된 치료적, 진단적, 및 항체 조성물의 혁신적 발견
WO2012041328A1 (en) 2010-10-01 2012-04-05 Nsgene A/S Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
JP6185463B2 (ja) 2011-07-15 2017-08-23 オンコメッド ファーマシューティカルズ インコーポレイテッド Ｒｓｐｏ結合剤およびその使用法
JP6145667B2 (ja) 2011-09-05 2017-06-14 ホーバ セラピューティクス アンパルトセルスカブ アロディニア、痛覚過敏、自発痛、及び幻痛の治療
EP2814514B1 (de) 2012-02-16 2017-09-13 Atyr Pharma, Inc. Histidyl-trna-synthetasen zur behandlung von autoimmun- und entzündungserkrankungen
US9181333B2 (en) 2012-07-13 2015-11-10 Oncomed Pharmaceuticals, Inc. RSPO3 binding agents and uses thereof
EP2742935A1 (de) * 2012-12-14 2014-06-18 Tissue Med Biosciences Forschungs- und Entwicklungsgesellschaft mbH SERF2 für die Atrophiebehandlung oder Steigerung des Zellwachstums
ES2708565T3 (es) 2013-03-15 2019-04-10 Atyr Pharma Inc Conjugados de Fc-histidil-ARNt sintetasa
EP2878335B1 (de) 2013-11-10 2018-01-03 Brainsgate Ltd. Implantat und implantationssystem für nervenstimulator
CA2961374A1 (en) 2014-09-16 2016-03-24 Oncomed Pharmaceuticals, Inc. Treatment of fibrotic diseases
US10271907B2 (en) 2015-05-13 2019-04-30 Brainsgate Ltd. Implant and delivery system for neural stimulator
EP3548039B1 (de) 2016-12-04 2023-07-19 Alavi Khorassani Moghadam, Marcel Victor Ribavirin zur verwendung bei der behandlung einer mitochondriellen erkrankung
US10905766B2 (en) * 2017-03-23 2021-02-02 Oregon State University Therapeutic compositions and methods for treatment of muscle wasting diseases
MX2019011769A (es) 2017-04-03 2019-11-07 Hoffmann La Roche Anticuerpos que se unen a steap-1.
CA3060514A1 (en) 2017-04-20 2018-10-25 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation
IL281470B2 (en) 2018-09-28 2025-08-01 Harvard College Cellular reprogramming to reverse aging and promote organ and tissue regeneration
US12274733B2 (en) 2018-09-28 2025-04-15 President And Fellows Of Harvard College Cellular reprogramming to reverse aging and promote organ and tissue regeneration
CN110910960B (zh) * 2019-11-30 2022-07-08 浙江天科高新技术发展有限公司 一种鲍曼不动杆菌分子血清型快速分析方法
AU2021394748A1 (en) * 2020-12-08 2023-06-08 Imagine Pharma Llc Compositions and methods for treating wounds
CA3217602A1 (en) * 2021-05-06 2022-11-10 Kenneth Petersen Prevention and treatment of chemotherapy-induced neuropathic pain
US12252518B2 (en) 2023-01-06 2025-03-18 Life Biosciences, Inc. Methods of treating non-arteritic anterior ischemic optic neuropathy
WO2025068459A2 (en) * 2023-09-29 2025-04-03 Universität Zu Köln Tool and method for disaggregation of polyq strech containing proteins

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998049306A1 (en) * 1997-04-29 1998-11-05 Incyte Pharmaceuticals, Inc. Human c-type lectin
WO1998054209A2 (en) * 1997-05-31 1998-12-03 Peptide Therapeutics Limited Human mast cell function-associated antigen (mafa) and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998049306A1 (en) * 1997-04-29 1998-11-05 Incyte Pharmaceuticals, Inc. Human c-type lectin
WO1998054209A2 (en) * 1997-05-31 1998-12-03 Peptide Therapeutics Limited Human mast cell function-associated antigen (mafa) and uses thereof

Non-Patent Citations (13)

* Cited by examiner, † Cited by third party
Title
DATABASE EBI 1 November 1996 (1996-11-01), XP002329122, retrieved from EBI Database accession no. Q04490 *
DATABASE EMBL [online] 15 November 1992 (1992-11-15), "Homo Sapiens P5-1 mRNA, complete cds.", XP002329509, retrieved from EBI Database accession no. HSMHP *
DATABASE EMBL [online] 19 January 1998 (1998-01-19), "nx26e06.s1 NCI_CGAP_GC4 Homo sapiens cDNA clone IMAGE:1257250 3', mRNA sequence.", XP002346073, retrieved from EBI Database accession no. AA742567 *
DATABASE EMBL [online] 25 January 1999 (1999-01-25), "CITBI-E1-2541D22.TR CITBI-E1 Homo sapiens genomic clone 2541D22, genomic survey sequence.", XP002346074, retrieved from EBI Database accession no. AQ356422 *
DATABASE EMBL [online] 27 August 1998 (1998-08-27), "Homo sapiens PAC clone RP4-701O16 from 7, complete sequence.", XP002346072, retrieved from EBI Database accession no. AC005531 *
DATABASE EMBL [online] 4 December 1998 (1998-12-04), "Homo sapiens DNA, P5-1-hom region.", XP002329406, retrieved from EBI Database accession no. D88650 *
DATABASE EMBL 21 April 1994 (1994-04-21), "H.sapiens P5-1g DNA", XP002329407, retrieved from EBI Database accession no. Z31714 *
DATABASE EMBL 30 June 1999 (1999-06-30), "wi73f11.x1 NCI_CGAP_Kid12 Homo sapiens cDNA clone IMAGE:2398989 3' similar to TR:Q04490 Q04490 P5-1 PROTEIN.", XP002329408, retrieved from EBI Database accession no. AI765329 *
DATABASE UniProt 1 June 1998 (1998-06-01), "Mast cell function-associated antigen", XP002346076, retrieved from EBI Database accession no. O43198 *
DATABASE UniProt 1 November 1998 (1998-11-01), "ITIM-containing receptor MAFA_l (Mast cell function-associated antigen homolog)", XP002346075, retrieved from EBI Database accession no. 075613 *
See also references of WO0157190A3 *
SHIINA TAKASHI ET AL.: "Physical mapping between the S and HLA-E genes in the human MHC class I region: Construction of a BAC, PAC, and cosmid contig", IMMUNOGENETICS, vol. 48, no. 6, November 1998 (1998-11-01), pages 402 - 407, XP002329404, ISSN: 0093-7711 *
VERNET C. ET AL.: "A novel coding sequence belonging to a new multicopy gene family mapping within the human MHC class I region", IMMUNOGENETICS, vol. 38, no. 1, 1993, pages 47 - 53, XP002904811, ISSN: 0093-7711 *

Also Published As

Publication number Publication date
WO2001057190A3 (en) 2006-11-16
AU2001234944A8 (en) 2006-12-21
AU2001234944A1 (en) 2001-08-14
EP1572987A2 (de) 2005-09-14
WO2001057190A2 (en) 2001-08-09
CA2399776A1 (en) 2001-08-09

Similar Documents

Publication Publication Date Title
AU2001234944A8 (en) Novel nucleic acids and polypeptides
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001243142A1 (en) Novel nucleic acids and polypeptides
AU2001290548A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
AU2001296235A1 (en) Novel nucleic acids and polypeptides
AU2001263006A1 (en) Novel nucleic acids and polypeptides
IL206414A0 (en) Novel receptor nucleic acids and polypeptides
AU2001233017A1 (en) Novel nucleic acids and polypeptides
AU2002246502A1 (en) Nucleic acids and polypeptides
AU2001241511A1 (en) Novel nucleic acids and polypeptides
AU2001250872A1 (en) Novel nucleic acids and polypeptides
AU2001292561A1 (en) Nucleic acids and polypeptides
WO2002016439A8 (en) Novel nucleic acids and polypeptides
GB0002814D0 (en) Nucleic acids and their uses
AU8308901A (en) Novel proteins and nucleic acids encoding same
AU1181802A (en) Novel proteins and nucleic acids encoding same
AU2001239889A1 (en) Polypeptides and nucleic acids encoding same
AU7005801A (en) Gp354 nucleic acids and polypeptides
AU2001263005A8 (en) Novel nucleic acids and polypeptides
AU2001256977A1 (en) Human sez6 nucleic acids and polypeptides
AU3099402A (en) Novel proteins and nucleic acids encoding same
AU2001234896A1 (en) Novel polypeptides and nucleic acids encoding same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020826

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

A4 Supplementary search report drawn up and despatched

Effective date: 20051012

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

RIC1 Information provided on ipc code assigned before grant

Ipc: C07H 21/04 20060101AFI20070319BHEP

17Q First examination report despatched

Effective date: 20080328

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20080515